{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:32:15Z","timestamp":1761647535779},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,21]],"date-time":"2013-07-21T00:00:00Z","timestamp":1374364800000},"content-version":"vor","delay-in-days":2212,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.curtheres.2007.08.006","type":"journal-article","created":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T22:04:10Z","timestamp":1195077850000},"page":"271-277","source":"Crossref","is-referenced-by-count":10,"title":["Loss of Smell (Anosmia) and Taste (Ageusia) in a Patient Treated with Pegylated Interferon Alfa and Ribavirin"],"prefix":"10.1016","volume":"68","author":[{"given":"Ahmed Yacoob","family":"Mayet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2007.08.006_bib1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-140-5-200403020-00010","article-title":"Peginterferon-alpha 2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose","volume":"140","author":"Hadziyannis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.curtheres.2007.08.006_bib2","doi-asserted-by":"crossref","first-page":"S471","DOI":"10.1046\/j.1440-1746.17.s4.13.x","article-title":"Emerging therapies of hepatitis B and C","volume":"17","author":"Chen","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib3","first-page":"412","article-title":"Solis Herruzo JA","volume":"24","author":"Manzano Alonso","year":"2001","journal-title":"IFN-induced anosmia and ageusia in chronic hepatitis C [in Spanish]. Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib4","first-page":"499","article-title":"Garcia Bengoechea M","volume":"23","author":"Fernandez Fernandez","year":"2000","journal-title":"Anosmia secondary to treatment with interferon in a patient with chronic hepatitis C [in Spanish]. Gastroenterol Hepatol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib5","first-page":"360","article-title":"Vitezic D","volume":"38","author":"Kraus","year":"2000","journal-title":"Anosmia induced with alpha interferon in a patient with chronic hepatitis C. Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2007.08.006_bib6","first-page":"122","article-title":"et al","volume":"93","author":"Maruyama","year":"1998","journal-title":"Interferon-induced anosmia in a patient with chronic hepatitis C. Am J Gastroenterol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib7","first-page":"239","article-title":"et al","volume":"30","author":"Naranjo","year":"1981","journal-title":"A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2007.08.006_bib8","series-title":"New York, NY: Thieme","article-title":"Taste and Smell Disorders","author":"Selden","year":"1997"},{"key":"10.1016\/j.curtheres.2007.08.006_bib9","series-title":"Physicians' Desk Reference Drug Guide for Mental Health Professionals","year":"2002"},{"key":"10.1016\/j.curtheres.2007.08.006_bib10","first-page":"1269","article-title":"Drug induced anosmia with nifedipine","volume":"32","author":"Kharoubi","year":"2003","journal-title":"Presse Med"},{"key":"10.1016\/j.curtheres.2007.08.006_bib11","first-page":"1805","article-title":"Kerr KL","volume":"21","author":"Doty","year":"2003","journal-title":"Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: A review. J Hypertens"},{"key":"10.1016\/j.curtheres.2007.08.006_bib12","first-page":"482","article-title":"Kasbekar N","volume":"17","author":"Ackerman","year":"1997","journal-title":"Disturbances of taste and smell induced by drugs. Pharmacotherapy"},{"key":"10.1016\/j.curtheres.2007.08.006_bib13","first-page":"1611","article-title":"et al","volume":"92","author":"Yakirevitch","year":"2005","journal-title":"Effects of cisplatin on olfactory function in cancer patients. BrJ Cancer"},{"key":"10.1016\/j.curtheres.2007.08.006_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1703716","article-title":"Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation","volume":"30","author":"Epstein","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.curtheres.2007.08.006_bib15","first-page":"732","article-title":"Sattely-Miller EA","volume":"855","author":"Schiffman","year":"1998","journal-title":"Effect of psychotropic drugs on taste responses in young and elderly persons. Ann NY Acad Sci"},{"key":"10.1016\/j.curtheres.2007.08.006_bib16","first-page":"1868","article-title":"Mathias CJ","volume":"38","author":"Young","year":"2004","journal-title":"Taste and smell disturbance with the alpha-adrenoceptor agonist midodrine. Ann Pharmacother"},{"key":"10.1016\/j.curtheres.2007.08.006_bib17","first-page":"1331","article-title":"Wolfensberger M","volume":"129","author":"Welge-Luessen","year":"2003","journal-title":"Reversible anosmia after amikacin therapy. Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.curtheres.2007.08.006_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1017\/S0022215100139386","article-title":"Pickles J","volume":"111","author":"Benjamin","year":"1997","journal-title":"Chlorine-induced anosmia. A case presentation. J Laryngol Otol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib19","first-page":"651","article-title":"Freeland AP","volume":"303","author":"Whittet","year":"1991","journal-title":"Anosmia due to nasal administration of corticosteroid. BMJ"},{"key":"10.1016\/j.curtheres.2007.08.006_bib20","first-page":"1546","article-title":"et al","volume":"24","author":"Bagheri","year":"2004","journal-title":"Follow-up of adverse drug reactions from peginterferon alfa-2b-ribavirin therapy. Pharmacotherapy"},{"key":"10.1016\/j.curtheres.2007.08.006_bib21","first-page":"567","article-title":"Sub-cortico-frontal encephalopathy and choreic movements related to recombinant interferon-alpha 2b","volume":"158","author":"Moulignier","year":"2002","journal-title":"Rev Neurol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib22","first-page":"59","article-title":"Shimoda M","volume":"23","author":"Sunami","year":"2000","journal-title":"Intravenous administration of levodopa ameliorated a refractory akathisia case induced by interferon-alpha. Clin Neuropharmacol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib23","first-page":"526","article-title":"Blum RH","volume":"28","author":"Nishihori","year":"2005","journal-title":"Severe action tremor related to interferon-alpha 2b therapy for malignant melanoma. Am J Clin Oncol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5737\/1181912x153161167","article-title":"Peripheral nerve function and symptom distress during biotherapy for malignant melanoma","volume":"15","author":"Visovsky","year":"2005","journal-title":"Can Oncol Nurs J"},{"key":"10.1016\/j.curtheres.2007.08.006_bib25","first-page":"431","article-title":"Michalewicz M","volume":"18","author":"Lapinski","year":"2005","journal-title":"The peripheral polyneuropathy in patients with chronic HCV infection treated peginterferon alfa with ribavirin [in Polish]. Pol Merkur Lekarski"},{"key":"10.1016\/j.curtheres.2007.08.006_bib26","first-page":"174","article-title":"Alexander GJ","volume":"25","author":"Hoare","year":"2005","journal-title":"Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection. J Interferon Cytokine Res"},{"key":"10.1016\/j.curtheres.2007.08.006_bib27","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.3748\/wjg.v11.i34.5392","article-title":"Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy","volume":"11","author":"Wong","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.curtheres.2007.08.006_bib28","first-page":"35","article-title":"Potential mechanisms of interferon neurotoxicity","volume":"4","author":"Bender","year":"1996","journal-title":"Cancer Pract"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X07000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X07000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T04:09:44Z","timestamp":1588046984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X07000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0011393X07000690"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2007.08.006","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}